01.11.2012
- Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...
31.10.2012
- French oil company Total reported a 20% rise in third-quarter net adjusted profit to €.348 billion on Wednesday, beating analysts' expectations thanks to a sharp increase in...
25.10.2012
- French drugmaker Sanofi forecast 2012 earnings would fall less than expected as cost cuts and demand for diabetes and rare disease drugs cushion the blow from patent expiries...
17.10.2012
- U.S. drug reviewers flagged several safety concerns, including possible cancer risks, related to Sanofi and Isis Pharmaceuticals's lipid disorder drug Kynamro, sending Isis's...
03.10.2012
- Drugmakers Sanofi and Bristol-Myers Squibb plan to revamp their 15-year-old alliance from Jan. 1 in response to lost exclusivity on two key drugs and the arrival of generic...
02.10.2012
- Giant French pharmaceutical maker Sanofi said Tuesday it would buy Colombian drugmaker Genfar to expand its product portfolio in South America. Genfar is Colombia's second-largest...
01.10.2012
- Sanofi is pleased to announce today the appointment of Dr. Paul Chew, Senior Vice President, Chief Medical Officer and Head of Global Medical Affairs as of January 1, 2013. Dr...
25.09.2012
- A Pill a Day - Unlike chemicals, the pharmaceuticals sector does not have cycles. Even in a sluggish economy, sick people will still need medicine. But the widening European debt...
25.09.2012
- Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...
24.09.2012
- French drugmaker Sanofi will reveal on Tuesday how it plans to shake up its French research operations in a cost-cutting drive which unions predict could mean up to 2,500 layoffs...
